Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mitsubishi Chemical (4188 JP)
Watchlist
51
Analysis
Materials
•
Japan
Mitsubishi Chemical Holdings Corporation is a holding company established through the merger of Mitsubishi Chemical and Mitsubishi Pharma. The Company manages operation of its subsidiaries.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Mitsubishi Chemical
•
11 Sep 2017 06:39
Fine Vs Commodity Chemicals – Are MMA Markets Sustainable?
Nissan Chemical Industries (4021 JP) presented at a conference in Tokyo this week, where part of its message was probably that the recent...
Pelham Smithers Associates
398 Views
Share
bullish
•
Mitsubishi Tanabe Pharma
•
27 Jul 2017 07:30
Mitsubishi Tanabe (4508) - Acquisition of NeuroDerm Playing to Strength, Not Weakness
The history of overseas acquisitions by Japanese drug companies is not a pretty one, as they've either overpaid for a skillset (Takeda (4502 JP)...
Pelham Smithers Associates
355 Views
Share
bearish
•
JSR Corp
•
29 May 2017 08:07
Japanese Chemicals: Chinese Policy Threatens Petrochemical Spreads
Spreads for many petrochemical products, including ethylene itself, were strong from the beginning of FY16, in part because of extended trouble at...
Pelham Smithers Associates
411 Views
Share
bearish
•
Nippon Sanso Holdings
•
08 Aug 2016 20:28
Taiyo Nippon Sanso - Next on Mitsubishi Chem's List? Possibly Not
Shares in Taiyo Nippon Sanso (TNS) gained ¥43 to ¥936 on the back on the Mitsubishi Chemical bid for Nippon Synthetic. The situation is not...
Pelham Smithers Associates
723 Views
Share
bullish
•
Nippon Synthetic Chemical
•
07 Aug 2016 20:45
Nippon Synthetic Chemical (4201) TOB
Friday August 5th after the close, Mitsubishi Chemical Holdings (4188 JP) (and its affiliates) announced a Tender Offer to take private Nippon...
Travis Lundy
Follow
586 Views
Share
First
Previous
7
8
9
10
11
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x